CIK 0001285819 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in WA · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | ||||
| Net income (USD) | 47.4 M | 194.2 M | -138.1 M | |
| Diluted EPS (USD/shares) | -0.05 | 0.76 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-24 | 4 | FORM 4 | 2026-09-22 |
| 2026-09-23 | 144 | 144 | |
| 2026-09-22 | 144 | 144 | |
| 2026-09-01 | 4 | FORM 4 | 2026-08-28 |
| 2026-08-31 | 144 | 144 | |
| 2026-08-28 | 144 | 144 | |
| 2026-08-28 | 4 | FORM 4 | 2026-08-26 |
| 2026-08-27 | 144 | 144 | |
| 2026-08-26 | 144 | 144 | |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-21 | 4 | FORM 4 | 2026-08-20 |
| 2026-08-21 | 144 | 144 | |
| 2026-08-20 | 144 | 144 | |
| 2026-08-18 | 4 | FORM 4 | 2026-08-12 |
| 2026-08-18 | 3 | FORM 3 | 2026-08-12 |
| 2026-08-17 | 4 | FORM 4 | 2026-08-13 |
| 2026-08-13 | 144 | 144 | |
| 2026-08-13 | S-8 | S-8 | |
| 2026-08-13 | 8-K | 8-K items 5.02 | 2026-08-12 |
| 2026-08-12 | 10-Q | FORM 10-Q | 2026-06-30 |
| 2026-08-12 | 8-K | FORM 8-K items 2.02,9.01 | 2026-08-12 |
| 2026-07-29 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-24 | 4 | FORM 4 | 2026-07-22 |
| 2026-07-24 | 4 | FORM 4 | 2026-07-22 |
| 2026-07-24 | 4 | FORM 4 | 2026-07-22 |
Forms on file (last 1,000): 4 276, 8-K 180, 10-Q 51, SC 13G/A 47, 424B5 28, CT ORDER 27, 3 17, DEF 14A 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=OMER (0.002 USD), /gw/filings/filings?ticker=OMER&form=8-K, /gw/filings/facts?ticker=OMER&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange